Nov 20, 2020 | COVID-19, Health News, Vaccines
Qualmedica Research is currently enrolling two clinical trials focused on a new antibody therapy developed by Eli Lilly. The BLAZE 1 study is for patients 0 – 17 years old with underlying risk factors. The BLAZE 4 study is recruiting patients 12+ with...
Aug 26, 2020 | Infant Nutrition Studies
Deciding whether to breastfeed or formula feed your child is a personal decision for every mom. Breastfeeding is an obvious choice, except when it isn’t. Birthing centers around the country are constantly promoting the benefits of breastfeeding (for good reason). ...
Aug 26, 2020 | Health News, Vaccines
Before a new vaccine is ever given to people, extensive lab testing is done that can take several years. Once testing in people begins, it can take several more years before clinical studies are complete and the vaccine is approved. The FDA sets rules for the three...
Aug 18, 2020 | COVID-19, Health News, Vaccines
The COVID-19 pandemic has caused quite the fear to our community. Qualmedica Research has compiled information in a Q&A format to update you on current efforts to develop drug therapies and vaccines. We hope you find this information helpful. Who is Qualmedica...
Jul 20, 2020 | Health News
Qualmedica Research is a multi-site clinical research company offering clinical trials in Bowling Green, KY; Owensboro, KY; and Evansville, IN. We are pleased to announce our recent expansion into Bowling Green and our relationship with the doctors and staff at...
